LamdaGen Introduces its LSPR Analytical Instrument, the LightPath™ S4 at AAPS in San Francisco, California

LamdaGen Corporation introduced the first commercially available Localized Surface Plasmon Resonance (LSPR) analytical instrument at the 2010 American Association of Pharmaceutical Scientists (AAPS) National Biotechnology Conference held May 17-19, 2010 at the Hilton San Francisco Union Square in San Francisco, California.

LamdaGen Corporation provides LigthPath S4 and LSPR biosensors to the Life Science and diagnostic markets, as well as functional nanomaterials to support various applications in plasmonics, cleantech and energy. Founded in 2005 and headquartered in Menlo Park, California, the company’s products are based upon its patented nano-structured surface technologies which produce highly robust sensors and sensor chips in the form of metallic thin films – and are the heart of the Company’s LightPath systems.

LightPath systems and sensors are used for real-time characterization of biomolecular, enzymatic and chemical type reactions and are the first commercially available LSPR-based products.

Leave a Reply

You must be logged in to post a comment.